Palatin Technologies Inc Stock News

Ultragenyx (RARE) delivered earnings and revenue surprises of -35.61% and 0.69%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

CRANBURY, N.J., Feb. 10, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter, fiscal year 2022 operating results on Tuesday, February 15, 2022, befor

Palatin Technologies, Inc. (PTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Palatin Technologies, Inc. (PTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRANBURY, N.J., Jan. 7, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modula

Add these three penny stocks to your January 2022 watchlist The post Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out appeared first on Penny Stocks to Buy, Picks, News and Informatio

Add these three penny stocks to your January 2022 watchlist The post Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out appeared first on Penny Stocks to Buy, Picks, News and Informatio

Palatin (PTN) commences the pivotal phase III study evaluating PL9643 for the treatment of dry eye disease. Top-line data from the same is expected in the second half of 2022.

Palatin (PTN) commences the pivotal phase III study evaluating PL9643 for the treatment of dry eye disease. Top-line data from the same is expected in the second half of 2022.

Shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.54. Palatin Technologies shares last traded at $0.54, with a volume of 2,104,395 shares traded. A number of equities research analysts recently weighed in […]

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) with the stream of 2.61% also noticed, India Palatin Technologies, Inc. (AMEX:PTN) encountered a rapid change of -2.81% in the last hour of Thursdays trading The post Traders cant mares this Stock: Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), Palatin Technologies, Inc. (AMEX:PTN) appeared first on Stocks Equity .

Shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.54. Palatin Technologies shares last traded at $0.54, with a volume of 2,104,395 shares traded. PTN has been the subject […]

Palatin Technologies Inc. (AMEX:PTN) traded at $0.52 at last check on Tuesday, December 21, made an upward move of 0.44% on its previous days price. Looking at the stock we see that its previous close was $0.52 and the beta (5Y monthly) reads 0.85 with the days price range being $0.51 $0.54. In terms Palatin Technologies Inc. (AMEX: PTN) Analysts Revisions Show Sentiment Is Improving Read More »

Chembio Diagnostics, Inc. (NASDAQ:CEMI) with the stream of 6.17% also noticed, India Palatin Technologies, Inc. (AMEX:PTN) encountered a rapid change of -3.27% in the last hour of Fridays trading session. The post Up to Date Trending Stock: Chembio Diagnostics, Inc. (NASDAQ:CEMI), Palatin Technologies, Inc. (AMEX:PTN) appeared first on Stocks Equity .

During the last session, Palatin Technologies Inc. (AMEX:PTN)s traded shares were 4.64 million, with the beta value of the company hitting 0.85. At the end of the trading day, the stocks price was $0.55, reflecting an intraday gain of 1.18% or $0.01. The 52-week high for the PTN share is $1.30, that puts it down During The Past Six Months, Palatin Technologies Inc. (AMEX: PTN) Shares Took An -6.30% Jump. Here Is What We Should Expect Read More »